elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36962376-BE192333-FD48-41D5-840D-FF30E97218E4
Q36962376-BE192333-FD48-41D5-840D-FF30E97218E4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36962376-BE192333-FD48-41D5-840D-FF30E97218E4
Hyperactive ERK and persistent mTOR signaling characterize vemurafenib resistance in papillary thyroid cancer cells.
P1433
Q36962376-BE192333-FD48-41D5-840D-FF30E97218E4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36962376-BE192333-FD48-41D5-840D-FF30E97218E4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8fd91e8fe72e8a9d20cf010cd1693e62dddfbad1
P1433
Oncotarget